---
title: "諾瓦瓦克斯醫藥 (NVAX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/NVAX.US/norm.md"
symbol: "NVAX.US"
name: "諾瓦瓦克斯醫藥"
parent: "https://longbridge.com/zh-HK/quote/NVAX.US.md"
datetime: "2026-05-21T06:27:02.029Z"
locales:
  - [en](https://longbridge.com/en/quote/NVAX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NVAX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NVAX.US/norm.md)
---

# 諾瓦瓦克斯醫藥 (NVAX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0581 | 0.1078 | -1.25 | 0.6159 | 2.93 |
| ROE | 27.86% | -49.30% | 1359.99% | -2241.21% | -593.18% |
| 營業收入 | 139.51M | 147.14M | 70.44M | 239.24M | 666.65M |
| 凈利潤 | -9.49M | 17.53M | -202.38M | 106.51M | 518.65M |
| 營業利潤 | -10.03M | 20.94M | -79.38M | 105.67M | 516.01M |
| 毛利率 | 19.42% | 7.60% | -47.21% | 66.44% | 86.51% |
| 凈利率 | -6.80% | 11.91% | -287.29% | 44.52% | 77.80% |
| 利潤含金量 | - | -53.04% | -73.63% | -82.90% | -278.17% |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 1.04B | 1.18B | 1.18B | 1.34B | 1.29B |
| 權益乘數 | -7.21 | -9.21 | -7.53 | 35.52 | -17.09 |
| 每股凈資產 | -0.8804 | -0.7858 | -0.9643 | 0.2320 | -0.4671 |
| 資產周轉率 | 0.5105 | 0.8210 | 0.7362 | 0.6838 | 0.9484 |
| 現金及短投 | 790.33M | 735.08M | 762.89M | 612.30M | 731.48M |
| 存貨與應收 | 11.46M | 11.54M | 13.51M | 10.24M | 10.26M |
| 長期投資 | 63.51M | 67.70M | 72.99M | 282.69M | 291.03M |
| 凈債務 | -495.27M | -457.04M | -511.75M | -383.81M | -502.82M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -32.42M | -39.48M | 107.80M | -127.46M | -185.50M |
| 投資現金流 | -28.36M | 20.48M | -136.53M | 111.10M | -73.32M |
| 融資現金流 | 37.67M | -6.60M | 42.44M | -1.04M | -7.06M |
| 自由現金流 | 78.74M | 15.16M | 100.26M | -121.47M | -311.81M |
| 現金流充裕率 | -1754.49% | -472.75% | 3592.27% | -14838.42% | -4886.78% |
| 舉債與償債 | 46.41M | 0.0000 | 42.61M | - | - |
| 資本支出 | -1.27M | -2.08M | -2.02M | -247000.00 | -1.59M |